Evidence map›Paper›PMID 41114155›Full record

ArticleACS omega2025

Enhanced Protein Precipitation with Ammonia Enables Rapid, Universal Extraction of Oligonucleotides for Bioanalysis.

Afrand Kamali, Juili D Shelke, Ethan J Sanford, Michael M Hayashi, Natthamon Chaisakhon, Robert V Kolakowski, Sanyogitta Puri, Guangnong Zhang

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Afrand KamaliNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.ORCID https://orcid.org/0009-0001-1451-2192
Juili D ShelkeNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.
Ethan J SanfordNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.
Michael M HayashiNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.
Natthamon ChaisakhonNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.
Robert V KolakowskiNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.
Sanyogitta PuriNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.
Guangnong ZhangNovo Nordisk Research & Development US Inc., 65 Hayden Ave, Lexington, Massachusetts 02421, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discovery, characterization, and development of oligonucleotides (ONTs) require a universal method that is low-cost and efficient, without requiring extensive method development for each new test article. Protein precipitation using organic solvents meets these criteria for small molecules but has historically failed for ONTs due to poor recovery arising from their tendency to coprecipitate with proteins. This study introduces an effective approach utilizing small amines dissolved in organic solvents to significantly boost the extraction recovery of ONTs from biological matrices. We first present the method's development and then analytically qualify it for the bioanalysis of antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) extracted from various tissues, using ion-pairing reverse phase (IPRP) liquid chromatography coupled to tandem MS and high resolution MS (HRMS) detection. This method, enhanced protein precipitation (EPP), achieves acceptable recovery for ASOs and siRNAs; greater than 80% and achievable LLOQ of 1-5 ng/mL for different ONTs in plasma and tissues. We demonstrate the method is suitable for recovering multiple ONT classes from biological matrices without the need of sample digestion, costly solid phase extraction plates, or custom-designed hybridization probes. The method has proven to be more versatile and sustainable than conventional approaches.

Identifiers

PMID41114155
PMCPMC12529115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.